Get startedLog in
    Picture of Magle Chemoswed Holding AB logo

    MAGLE — Magle Chemoswed Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Sweden's Magle Chemoswed posts Q4 loss on restructuring measures

    Picture of Magle Chemoswed Holding AB logoMagle Chemoswed Holding AB
    27/03/2026 07:39
    Overview

Sweden CDMO's Q4 net sales fell yr/yr amid restructuring and portfolio clean-up measures

Company reported negative EBITDA and EBIT for Q4 2025

Restructuring and cost reduction efforts impacted short-term financial results

Outlook

Company prioritizes improving profitability and capital efficiency through ongoing portfolio and cost structure adjustments

Result Drivers

RESTRUCTURING MEASURES - Co said restructuring actions and portfolio clean-up affected short-term financial results

BUSINESS FOCUS - Co said it is directing resources towards areas with strongest commercial traction and most predictable returns

Company press release: ID:nMFN3xHQ06

Key Details


    MetricBeat/MissActualConsensus Estimate
    Q4 SalesSEK 77.70 mln
    Q4 EPS-SEK 6.49
    Q4 EBIT-SEK 120.30 mln
    Q4 EBITDA-SEK 58.50 mln
    

Analyst Coverage

Wall Street's median 12-month price target for Magle Chemoswed Holding AB is SEK25.00, about 486.9% above its March 26 closing price of SEK4.26

The stock recently traded at 3 times the next 12-month earnings vs. a P/E of 15 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

    Recent news on Magle Chemoswed Holding AB

    See all news